Kyri Van Hoose's most recent trade in Dermata Therapeutics Inc was a trade of 18,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dermata Therapeutics Inc | Kyri K. Van Hoose | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 18,000 | 18,000 | - | - | Stock Option (right to buy) | |
| Dermata Therapeutics Inc | Kyri K. Van Hoose | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 122,549 | 130,423 | - | - | Common Stock | |
| Dermata Therapeutics Inc | Kyri K. Van Hoose | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 122,549 | 122,549 | - | - | Series C Warrant (Right to Buy) | |
| Dermata Therapeutics Inc | Kyri K. Van Hoose | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 122,549 | 122,549 | - | - | Series D Warrant (Right to Buy) | |
| Dermata Therapeutics Inc | Kyri K. Van Hoose | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 7,874 | 7,874 | - | - | Warrant (Right to Buy) | |
| Dermata Therapeutics Inc | Kyri K. Van Hoose | SVP, CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Dec 2025 | 7,874 | 0 | - | - | Warrant (Right to Buy) | |
| Dermata Therapeutics Inc | Kyri K. Van Hoose | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 78,741 | 78,741 | - | - | Common Stock | |
| Dermata Therapeutics Inc | Kyri K. Van Hoose | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 78,741 | 78,741 | - | - | Warrant (Right to Buy) | |
| Dermata Therapeutics Inc | Kyri K. Van Hoose | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2025 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Dermata Therapeutics Inc | Kyri K. Van Hoose | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Dermata Therapeutics Inc | Kyri K. Van Hoose | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Dermata Therapeutics Inc | Kyri K. Van Hoose | SVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Dermata Therapeutics Inc | Kyri Van Hoose | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2021 | 75,000 | 75,000 | - | - | Stock Option (right to Buy) |